Company / Revenue per Share
TENAX THERAPEUTICS, INC. Revenue per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2025
5-year range
$0.00 / $0.62
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.01 to $0.00 over the past 9 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | -100.0% |
| FY2016 | $0.01 | -0.9% |
| FY2015 | $0.01 | -99.1% |
| FY2014 | $0.62 | +149.5% |
| FY2013 | $0.25 | +5508.0% |
| FY2012 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026